Log in to save to my catalogue

O17 Multi-centre validation of UC-CaRE: a cancer risk prediction tool for colitis-associated low gra...

O17 Multi-centre validation of UC-CaRE: a cancer risk prediction tool for colitis-associated low gra...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2479625436

O17 Multi-centre validation of UC-CaRE: a cancer risk prediction tool for colitis-associated low grade dysplasia

About this item

Full title

O17 Multi-centre validation of UC-CaRE: a cancer risk prediction tool for colitis-associated low grade dysplasia

Publisher

London: BMJ Publishing Group LTD

Journal title

Gut, 2021-01, Vol.70 (Suppl 1), p.A9-A10

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

IntroductionUlcerative colitis (UC) patients diagnosed with low grade dysplasia (LGD) are at increased risk of developing high grade dysplasia (HGD) and colorectal cancer (CRC); together termed advanced neoplasia (AN). We aimed to develop and validate a predictor of AN risk in UC-LGD patients and create a visual risk communication web-tool.MethodsW...

Alternative Titles

Full title

O17 Multi-centre validation of UC-CaRE: a cancer risk prediction tool for colitis-associated low grade dysplasia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2479625436

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2479625436

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2020-bsgcampus.17

How to access this item